Cohet Catherine, Cheng Soo, MacDonald Claire, Baker Michael, Foliaki Sunia, Huntington Nyk, Douwes Jeroen, Pearce Neil
Centre for Public Health Research, Research School of Public Health, Massey University Wellington Campus, Private Box 756, Wellington, New Zealand.
J Epidemiol Community Health. 2004 Oct;58(10):852-7. doi: 10.1136/jech.2003.019182.
The "hygiene hypothesis" postulates that infections during infancy may protect against asthma and atopy. There is also some evidence that antibiotic and/or paracetamol use may increase the risk of asthma.
The study measured the association between infections, and medication use early in life and the risk of asthma at age 6-7 years. It involved 1584 children who had been notified to public health services with serious infections at age 0-4 years, and 2539 children sampled from the general population. For both groups, postal questionnaires were completed by parents.
There was little difference in the prevalence of current wheezing between the childhood infections group (prevalence = 23.5%) and the general population group (prevalence = 24.3%). There was also little difference whether the major site of infection was gastrointestinal (prevalence = 24.1%), invasive (prevalence = 24.6%) or respiratory (prevalence = 21.1%). However, in both groups, there were associations with antibiotic (OR = 1.78, 95% CI 1.49 to 2.14) or paracetamol (OR = 1.38, 95% CI 1.04 to 1.83) use in the first year of life or recent paracetamol use (OR = 2.10, 95% CI 1.78 to 2.49) and current wheezing. There was a weak protective effect of childhood infections in children who had not used antibiotics in the first year of life (OR = 0.78, 95% CI 0.55 to 1.10).
These findings are consistent with other evidence that antibiotic use early in life may increase the risk of asthma. They are also consistent with some preliminary evidence associating paracetamol use with an increased risk of asthma. Any protective effect of notifiable childhood infections was weak.
“卫生假说”假定婴儿期感染可预防哮喘和特应性疾病。也有一些证据表明使用抗生素和/或对乙酰氨基酚可能增加哮喘风险。
该研究测量了生命早期感染、药物使用与6至7岁时哮喘风险之间的关联。研究纳入了1584名0至4岁时因严重感染而被上报至公共卫生服务机构的儿童,以及从普通人群中抽取的2539名儿童。两组儿童的家长均通过邮寄问卷的方式完成调查。
儿童感染组(患病率=23.5%)和普通人群组(患病率=24.3%)当前喘息的患病率差异不大。感染主要部位为胃肠道(患病率=24.1%)、侵袭性感染(患病率=24.6%)或呼吸道感染(患病率=21.1%)时,差异也不大。然而,在两组中,生命第一年使用抗生素(比值比=1.78,95%置信区间1.49至2.14)或对乙酰氨基酚(比值比=1.38,95%置信区间1.04至1.83),或近期使用对乙酰氨基酚(比值比=2.10,95%置信区间1.78至2.49)与当前喘息均有关联。在生命第一年未使用抗生素的儿童中,儿童期感染有较弱的保护作用(比值比=0.78,95%置信区间0.55至1.10)。
这些发现与其他证据一致,即生命早期使用抗生素可能增加哮喘风险。它们也与一些将对乙酰氨基酚使用与哮喘风险增加相关联的初步证据一致。儿童期可报告感染的任何保护作用都很弱。